The proposal would make menopause treatments affordable and accessible under the following components:

Component 1: Provide $50 million annually to make menopause treatments more affordable and accessible. This Commonwealth funding should go towards:

• Subsidising TGA approved menopausal hormone therapy (MHT).
• Purchasing more doses of MHT and making them more accessible across Australia.
• Purchasing alternative forms of MHT medications.

Component 2:

• Create a Medicare Benefits Scheme (MBS) item so GPs can provide more comprehensive tests for conditions related to menopause, including essential bone density scans.
• Removing the PBS co-payment for menopause treatments.

The proposal would be ongoing and start on 1 July 2026.